See more : Cedar Woods Properties Limited (CWP.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Aspen Pharmacare Holdings Limited (APNHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aspen Pharmacare Holdings Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Queen’s Gambit Growth Capital (GMBTW) Income Statement Analysis – Financial Results
- PolyNovo Limited (PNV.AX) Income Statement Analysis – Financial Results
- Venus Remedies Limited (VENUSREM.BO) Income Statement Analysis – Financial Results
- Gold Rain Enterprises Corp. (4503.TWO) Income Statement Analysis – Financial Results
- SKF India Limited (SKFINDIA.NS) Income Statement Analysis – Financial Results
Aspen Pharmacare Holdings Limited (APNHF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.aspenpharma.com
About Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44.71B | 40.71B | 38.61B | 37.77B | 38.65B | 38.87B | 38.31B | 41.21B | 35.60B | 36.10B | 29.52B | 19.31B | 15.26B | 12.38B | 9.62B | 8.44B | 4.68B | 4.03B | 3.45B | 2.81B | 2.20B | 1.90B |
| Cost of Revenue | 25.25B | 22.30B | 20.30B | 19.98B | 19.31B | 19.17B | 18.63B | 21.32B | 17.70B | 18.80B | 15.79B | 10.08B | 7.98B | 6.77B | 5.14B | 4.56B | 2.51B | 2.08B | 1.79B | 1.42B | 1.14B | 1.04B |
| Gross Profit | 19.45B | 18.41B | 18.31B | 17.79B | 19.33B | 19.70B | 19.69B | 19.90B | 17.90B | 17.30B | 13.72B | 9.23B | 7.28B | 5.61B | 4.48B | 3.88B | 2.17B | 1.94B | 1.66B | 1.39B | 1.06B | 860.84M |
| Gross Profit Ratio | 43.52% | 45.22% | 47.42% | 47.10% | 50.02% | 50.67% | 51.38% | 48.28% | 50.28% | 47.92% | 46.49% | 47.81% | 47.70% | 45.33% | 46.54% | 45.93% | 46.37% | 48.23% | 48.13% | 49.41% | 48.06% | 45.29% |
| Research & Development | 162.00M | 214.00M | 433.00M | 260.00M | 195.00M | 211.00M | 111.00M | 188.00M | 200.00M | 200.00M | 53.30M | 42.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.63B | 1.68B | 1.48B | 1.84B | 1.60B | 1.65B | 1.62B | 1.43B | 1.40B | 2.90B | 1.65B | 1.37B | 1.10B | 827.30M | 740.40M | 587.50M | 272.30M | 745.09M | 658.09M | 550.80M | 435.56M | 365.59M |
| Selling & Marketing | 6.47B | 2.92B | 2.92B | 3.08B | 3.43B | 3.52B | 3.47B | 4.08B | 3.40B | 5.60B | 4.40B | 2.34B | 1.97B | 1.46B | 1.15B | 997.70M | 665.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 10.10B | 4.60B | 4.40B | 4.93B | 5.03B | 5.17B | 5.08B | 5.51B | 4.80B | 8.50B | 6.05B | 3.71B | 3.07B | 2.29B | 1.89B | 1.59B | 937.60M | 745.09M | 658.09M | 550.80M | 435.56M | 365.59M |
| Other Expenses | 2.19B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -72.85M | -1.04M | 553.76M | 0.00 |
| Operating Expenses | 12.46B | 9.47B | 9.47B | 8.60B | 10.37B | 10.33B | 9.82B | 10.15B | 7.70B | 8.90B | 6.30B | 4.19B | 3.34B | 2.46B | 1.95B | 1.70B | 975.00M | 865.02M | 765.55M | 897.20M | 504.35M | 413.99M |
| Cost & Expenses | 37.71B | 31.77B | 29.77B | 28.57B | 29.68B | 29.51B | 28.45B | 31.46B | 25.40B | 27.70B | 22.09B | 14.26B | 11.32B | 9.23B | 7.09B | 6.27B | 3.49B | 2.95B | 2.55B | 2.32B | 1.65B | 1.45B |
| Interest Income | 999.00M | 509.00M | 92.00M | 108.00M | 141.00M | 213.00M | 182.00M | 259.00M | 300.00M | 400.00M | 245.70M | 298.80M | 2.10M | 3.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.23B | 1.32B | 765.00M | 1.21B | 1.58B | 2.33B | 2.16B | 2.16B | 2.00B | 2.00B | 1.43B | 844.00M | 752.60M | 611.10M | 553.20M | 699.20M | 280.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.97B | 1.79B | 1.71B | 1.65B | 1.60B | 1.27B | 1.37B | 1.27B | 1.20B | 1.00B | 823.80M | 494.70M | 228.00M | 359.40M | 269.70M | 223.60M | 202.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 9.91B | 9.67B | 10.61B | 8.85B | 7.45B | 5.85B | 10.28B | 9.68B | 10.50B | 9.50B | 8.61B | 5.33B | 4.19B | 3.35B | 2.98B | 2.62B | 1.66B | 1.08B | 894.74M | 493.42M | 553.76M | 446.85M |
| EBITDA Ratio | 22.18% | 25.97% | 27.73% | 26.08% | 27.63% | 28.30% | 30.41% | 27.03% | 29.49% | 26.32% | 29.45% | 27.22% | 27.32% | 27.03% | 30.98% | 31.03% | 35.47% | 26.74% | 25.94% | 17.53% | 25.15% | 23.51% |
| Operating Income | 7.00B | 7.82B | 8.67B | 7.07B | 7.06B | 4.81B | 8.51B | 8.32B | 9.00B | 8.40B | 7.42B | 5.04B | 3.94B | 3.15B | 2.52B | 2.17B | 1.20B | 1.08B | 894.74M | 493.42M | 553.76M | 446.85M |
| Operating Income Ratio | 15.65% | 19.21% | 22.46% | 18.73% | 18.27% | 12.37% | 22.20% | 20.19% | 25.28% | 23.27% | 25.16% | 26.12% | 25.83% | 25.43% | 26.24% | 25.76% | 25.55% | 26.74% | 25.94% | 17.53% | 25.15% | 23.51% |
| Total Other Income/Expenses | -1.28B | -1.27B | -537.00M | -1.08B | -1.53B | -1.93B | -1.76B | 13.00M | -2.90B | -1.90B | -1.07B | -553.90M | -500.60M | -412.10M | -367.00M | -478.30M | -18.40M | -67.25M | -40.83M | -99.44M | -25.29M | -57.94M |
| Income Before Tax | 5.71B | 6.56B | 8.13B | 5.99B | 5.60B | 2.77B | 6.74B | 6.25B | 6.10B | 6.50B | 6.36B | 4.49B | 3.44B | 2.74B | 2.16B | 1.70B | 1.18B | 1.01B | 853.91M | 393.99M | 528.47M | 388.91M |
| Income Before Tax Ratio | 12.78% | 16.10% | 21.07% | 15.86% | 14.50% | 7.13% | 17.60% | 15.17% | 17.13% | 18.01% | 21.54% | 23.25% | 22.55% | 22.10% | 22.43% | 20.10% | 25.16% | 25.07% | 24.76% | 14.00% | 24.00% | 20.46% |
| Income Tax Expense | 1.31B | 1.33B | 1.65B | 1.19B | 991.00M | 774.00M | 1.12B | 1.12B | 1.80B | 1.30B | 1.35B | 975.30M | 772.30M | 582.10M | 458.50M | 358.90M | 333.10M | 291.72M | 216.36M | 207.57M | 172.89M | 115.50M |
| Net Income | 4.40B | 5.23B | 6.49B | 4.81B | 4.66B | 6.46B | 6.04B | 5.13B | 4.30B | 5.20B | 5.01B | 3.52B | 2.82B | 2.58B | 1.99B | 1.34B | 862.90M | 717.32M | 637.80M | 186.42M | 355.58M | 270.65M |
| Net Income Ratio | 9.85% | 12.84% | 16.81% | 12.73% | 12.07% | 16.63% | 15.76% | 12.44% | 12.08% | 14.40% | 16.97% | 18.23% | 18.47% | 20.82% | 20.68% | 15.88% | 18.43% | 17.82% | 18.49% | 6.62% | 16.15% | 14.24% |
| EPS | 9.91 | 11.77 | 14.32 | 10.53 | 10.22 | 14.16 | 13.23 | 11.23 | 9.45 | 11.40 | 10.98 | 7.73 | 6.46 | 5.96 | 4.95 | 3.75 | 2.45 | 2.06 | 1.85 | 0.55 | 1.00 | 0.77 |
| EPS Diluted | 9.91 | 11.77 | 14.32 | 10.53 | 10.22 | 14.16 | 13.23 | 11.23 | 9.45 | 11.40 | 10.98 | 7.72 | 6.23 | 5.72 | 4.75 | 3.63 | 2.40 | 2.02 | 1.79 | 0.53 | 0.02 | 0.75 |
| Weighted Avg Shares Out | 444.22M | 444.20M | 453.00M | 456.50M | 456.50M | 456.40M | 456.40M | 456.40M | 456.40M | 456.30M | 456.12M | 455.40M | 436.30M | 432.91M | 426.16M | 382.66M | 374.70M | 371.62M | 369.79M | 340.61M | 356.22M | 353.08M |
| Weighted Avg Shares Out (Dil) | 444.20M | 444.20M | 453.00M | 456.50M | 456.50M | 456.40M | 456.40M | 456.40M | 456.50M | 456.50M | 456.22M | 456.03M | 455.16M | 454.36M | 426.16M | 382.66M | 374.70M | 371.62M | 369.79M | 350.21M | 365.79M | 361.82M |
Source: https://incomestatements.info
Category: Stock Reports